how the bio bull will effect australia, page-5

No doubt that trials are a long and tedious process. The catalyst I am looking for is funding.

If I had a choice to list here or in US it would be Aus. US is fully priced there is much more upside here. Secondly there is less restrictions to list in a reputeable exchange such as asx as opposed to blu chip nasdaq.

Make no mistake Cynata directors will make bucket loads from this 200m shares, or about 40% of ECQ's current shares.

This is all about doing deals amongst deal makers. Who knows the connections between cynata, ecq and the warf.

All I know is the WARF, Sluvkin and Washer are deal makers. Add this to history / peer analysis and I am willing to be a part of that deal as a shareholder.